An oral solid tablet containing a Bruton's tyrosine kinase inhibitor and its preparation method

TW202639134APending Publication Date: 2026-10-01BEONE MEDICINES I GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115120715
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-06-10
Filing Date
2020-06-10
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001079703_001
    Figure TWG2TA001079703_001
  • Figure TWG2TA001079703_002
    Figure TWG2TA001079703_002
  • Figure TWG2TA001079703_003
    Figure TWG2TA001079703_003
Patent Text Reader

Abstract

This invention provides an oral solid tablet containing (S)-7-[4-(1-acrylylhexahydropyridine)]-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-methamide and its preparation method. The oral solid tablet of this invention has good drug release characteristics, is convenient to administer, releases rapidly and efficiently, requires no special equipment, has a simple formulation process, ensures formulation stability, is easy to transport and store, and is suitable for large-scale production.
Need to check novelty before this filing date? Find Prior Art